showed a trendP = 0.095
Patients with upper airway abnormalities were more likely to require additional doses ( P = 0.001) and showed a trend toward increased adverse events ( P = 0.095).
Patients with upper airway abnormalities were more likely to require additional doses ( P = 0.001) and showed a trend toward increased adverse events ( P = 0.095).
Although this trend did not reach statistical significance, it aligns with existing evidence indicating that pediatric patients with OSA have increased anesthesiological risk due to their heightened sensitivity to sedative and opioid medications, which can exacerbate airway obstruction and respiratory depression [ 20 – 22 ].